IP Library Assignment 029229/0637
Patent Assignment
Reel/Frame 029229/0637

Change of Name

Recorded: 2012-11-01 Pages: 4
Assignor
AMYLIN PHARMACEUTICALS, INC.
Executed: 2012-08-08
Assignee
AMYLIN PHARMACEUTICALS, LLC
9360 TOWNE CENTER DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Property (1)
Glp-1 Receptor Agonist Bioassays
Patent: 8,329,419 →
Application: 12/990,693 →
Publication: US 2011/0097751
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Nov 8, 2011
From: AMYLIN PHARMACEUTICALS, INC.
To: ELI LILLY AND COMPANY
Reel/Frame 027192/0334 →
Release of Security Interest Oct 1, 2012
From: ELI LILLY AND COMPANY
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 029057/0342 →
Change of Name Oct 25, 2012
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 029198/0396 →
Amylin Pharmaceuticals, Llc Assigns an Equal and Undivided One-Half of Its Entire Right, Title and Interest to Astrazeneca Pharmaceuticals Lp Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →